Neurorehabilitation Devices
North America · 1 shared keyword
Updated
Reviewed by Chandani Patel
North America Neurology Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$8.43 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $7.29 Bn | — | — |
| 2025 (base) | $7.91 Bn | +$612.7 Mn | — |
| 2026 (forecast) | $8.57 Bn | +$664.2 Mn | +8.4% |
| 2027 (forecast) | $9.29 Bn | +$720.0 Mn | +17.5% |
| 2028 (forecast) | $10.07 Bn | +$780.5 Mn | +27.4% |
| 2029 (forecast) | $10.92 Bn | +$846.0 Mn | +38.1% |
| 2030 (forecast) | $11.83 Bn | +$917.1 Mn | +49.7% |
| 2031 (forecast) | $12.83 Bn | +$994.1 Mn | +62.2% |
| 2032 (forecast) | $13.91 Bn | +$1.08 Bn | +75.9% |
| 2033 (forecast) | $15.07 Bn | +$1.17 Bn | +90.6% |
| 2034 (forecast) | $16.34 Bn | +$1.27 Bn | +106.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $7.91 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $16.34 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Boston Scientific Corporation, Abbott Laboratories, Stryker, Integra Life Sciences Corporation and 1 more (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Neurology devices diagnose and treat diseases of the brain, spine and nerves, such as stimulators, monitors and shunts.
Key segments of the neurology devices market include product (Neurostimulators, Neurovascular Devices and Cerebrospinal Fluid Management) and application (Epilepsy, Parkinson's Disease and Chronic Pain).
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the neurology devices market.
Smart implants, less invasive techniques and growing access to surgery in emerging economies give the neurology devices market room to grow.
Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the neurology devices market.
The neurology devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the countries we cover here, medical devices are regulated by Health Canada (Canada)[1] and FDA (US)[2]. How care is paid for in these countries: provincial health insurance (Canada)[3] and Medicare and Medicaid (US)[4].
[1] Health Canada. Checked 14 Nov 2026.
[2] US Food and Drug Administration. Checked 14 Nov 2026.
[3] Health Canada. Checked 14 Nov 2026.
[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurology devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in North America.
From our blog
North America · 1 shared keyword
North America · 1 shared keyword
North America
North America
North America
North America
Digital Health · North America
Pharmaceuticals · North America
Pharmaceuticals · North America
Healthcare Services · North America
Pharmaceuticals · North America
Pharmaceuticals · North America